Representative Gus Bilirakis (R-FL) was among several members of Congress who celebrated the recent reestablishment of the Longevity Science Caucus, saying, "Increasing life expectancy and promoting positive health outcomes are important priorities."
As the name suggests, the Longevity Science Caucus seeks to promote research and policy on aging and biotechnology, allowing Americans to live healthier, longer lives.
Studying in this field comes at a time when many Americans, as noted by Representative David Schweikert (R-AZ), are growing older, and not enough children are being born to offset the population being chipped away by time.
As a result, as Rep. Bilirakis noted in his press release, "proactive investment can significantly reduce the long-term economic and healthcare burdens on society," such as promoting greater focus on personal health, extending productivity lifespans, and lowering healthcare costs.
"Increasing life expectancy and promoting positive health outcomes are important priorities, and the formation of this caucus is an important step toward achieving those goals," Rep. Bilirakis said, adding, "I believe in promoting individual responsibility and supporting innovation in the pursuit of scientific discoveries that will enable Americans to live happier and longer lives. I am honored to co-chair this bipartisan effort with my colleague, Congressman Tonko. We will work with our colleagues in an effort to make a significant impact on the future health and wellness for our constituents."
Chairing the reestablished Caucus is Representative Paul Tonko (D-NY), who said, "With life expectancy in the United States at its lowest in decades, we in Congress need to come together to address this decline and support science and research that will enable people to live fuller and healthier lives. We’re doing just that with the Longevity Caucus."
"I am grateful for the partnership of Congressman Bilirakis in leading this Caucus and look forward to working in strong bipartisan fashion to help improve our quality and longevity of life, particularly in the fight against neurodegenerative diseases with aging as the greatest risk factor," Tonko concluded.
